Tag: Collaboration
Centogene And PTC Therapeutics Collaborate To Deliver A Diagnostic Program For AADC Deficiency
CENTOGENE N.V., a commercial-stage company focused on rare
diseases that transforms real-world clinical and genetic data into actionable
information for patients, physicians and pharmaceutical companies, has signed
an agreement with PTC Therapeutics, Inc. (PTC) for a global diagnostic program
for aromatic L-amino acid...
CENTOGENE And Pfizer Collaborating For Rare Disease Patients
CENTOGENE, a commercial-stage company focused on rare
diseases that transforms real-world clinical and genetic data into actionable
information for patients, physicians and pharmaceutical companies, has a new
data access and collaboration agreement with Pfizer Inc. The agreement grants
Pfizer access to CENTOGENE’s data...
Owlstone Medical Joins 3TR To Provide Breath Biopsy Infrastructure And Analysis For Multiple Studies
Owlstone Medical, the global leader in Breath Biopsy® for
applications in early disease detection and precision medicine has joined 3TR,
a large-scale public-private research initiative that aims to provide new
insights into the mechanisms of response and non-response to treatment within
and across...
The Thailand CELS And PhenoMx Sign MOU With Potential Biobanking Projects
The Thailand Center of Excellence for Life Sciences (TCELS),
a public organisation, and PhenoMx, Inc., a US-based health technology company,
announced the execution of a Memorandum of Understanding (MOU) to develop
strategic initiatives for Thailand in the biomedical, life science and medical
device...
4D Pharma And MSD Collaborate Leveraging The Microbiome To Develop Live Biotherapeutic Vaccines
4D pharma plc, a pharmaceutical company leading the
development of Live Biotherapeutics, has entered into a research collaboration
and option to license agreement with MSD, the tradename of Merck & Co.,
Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics
("LBPs") for...
Predictive Laboratories And The Preeclampsia Foundation Collaborate To Accelerate Research
Predictive Technology Group, Inc., a leader in the use of
data analytics for disease identification and subsequent precision therapeutic
intervention, has announced that its wholly owned subsidiary Predictive
Laboratories has entered into a research collaboration with the Preeclampsia
Foundation to expand the study...
Orgenesis Reports Cell Therapy Expansion Via Collaboration Agreements Including The Biobank Sector
Orgenesis Inc. a developer, manufacturer and service provider of advanced cell therapies, recently released financial results and provided a business update for the fiscal year ended November 30, 2018. A variety of deals were made during the year including...
Cytox To Make Use Of Mayo Clinic’s Alzheimer’s Biobank
Cytox is a precision medicine company with a focus on neurodegenerative disorders such as Alzheimer’s disease. The Cytox scientific and proprietary technology platform is being applied to the prediction of cognitive decline and neurodegenerative disorder risk.
The Mayo Clinic is...
